Accrued expenses and other current liabilities

12 Months Ended

Dec. 31, 2024

Payables and Accruals [Abstract]

Accrued expenses and other current liabilities

Accrued expenses and other current liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):

	As of December 31,
	2024		2023
Accrued expenses and other current liabilities:
Accrued research and development	$	10,064	$	11,243
Accrued compensation and benefits	7,428		7,344
Other	1,871		2,043
Total accrued expenses and other current liabilities	$	19,363	$	20,630

As of December 31, 2023, there were $3.1 million of costs related to wind down activities for CFT8634 included within the accrued research and development balance.